Currently, the drug is FDA-approved as a treatment for obesity, which is a risk factor for type 2 diabetes
Why Geneva Uses a Personalized Approach Geneva does not follow one-size-fits-all protocols for medical weight loss
doi: 10.3389/fphar.2021.718147 Received 09 June 2021 Accepted 17 November 2021 Published 13 December 2021 Volume 12 - 2021 Edited by Fan Jiang, Shandong University, China Reviewed by Dechang Chen, Shanghai Jiao Tong University, China Ying Li, Xian Jiaotong University, China Updates Copyright 2021 Tepes, Gojkovic, Krezic, Zizek, Vranes, Madzar, Santak, Batelja, Milavic, Sikiric, Kocman, Simonji, Samara, Knezevic, Barisic, Lovric, Strbe, Kokot, Sjekavica, Kolak, Skrtic, Seiwerth, Boban Blagaic and Sikiric
Medicine, 98 (37)
First observed in the SUSTAIN-6 trial, Rapid HbA1c reduction has been associated with worsening of pre-existing diabetic retinopathy [16]
Liraglutide is a medication that contains the same active ingredient and provides the same benefits as brand-name Saxenda